Hershey Trust CO Jounce Therapeutics, Inc. Transaction History

Hershey Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.11 - $9.64 $120,528 - $163,417	-16,952 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $25,179 - $43,615	-4,996 Reduced 22.76%	16,952 $126,000
Q2 2021 Aug 11, 2021	BUY	$6.58 - $10.66 $79,341 - $128,538	12,058 Added 121.92%	21,948 $149,000
Q1 2021 Apr 29, 2021	BUY	$6.73 - $13.87 $9,536 - $19,653	1,417 Added 16.72%	9,890 $102,000
Q4 2020 Jan 21, 2021	BUY	$6.37 - $10.33 $53,973 - $87,526	8,473 New	8,473 $59,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.